ask="16.600"
ask_size="500"
average_daily_volume="709189"
bid="10.500"
bid_size="300"
book_value="9.229"
change="-0.945"
change_from_200_day_moving_average="-11.999"
change_from_50_day_moving_average="0.436"
change_from_52_week_high="-37.435"
change_From_52_week_low="4.805"
change_in_percent="-5.710%"
close="15.605"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.730"
ebitda="-119.41M"
eps_estimate_current_year="-2.820"
eps_estimate_next_quarter="-0.800"
eps_estimate_next_year="-3.280"
ex_dividend_date="N/A"
float_shares="33663000"
high="16.710"
high_52_weeks="53.040"
last_trade_date="1/11/2017"
last_trade_price="15.605"
last_trade_size="19365"
last_trade_time="4:00pm"
low="15.320"
low_52_weeks="10.800"
market_capitalization="675.20M"
moving_average_200_day="27.604"
moving_average_50_day="15.169"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.630"
open="16.580"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-43.468%"
percent_change_from_50_day_moving_average="+2.874%"
percent_change_from_52_week_high="-70.579%"
percent_change_from_52_week_low="+44.491%"
previous_close="16.550"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.793"
price_per_sales="2717.942"
revenue="263466.00"
shares_outstanding="43268000"
short_ratio="6.780"
stock_exchange="NMS"
symbol="ITCI"
volume="563128"
weeks_range_52="10.800 - 53.040"
